1Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom; 2Clinical Trials Research Unit, University of Leeds, Leeds, United Kingdom; 3St James’s University Hospital, Leeds, United Kingdom; 4Nottingham University Hospital, Nottingham, United Kingdom; 5Royal Devon and Exeter Hospital, Exeter, United Kingdom; 6Western General Hospital, Edinburgh, United Kingdom; 7University o...

Adolfsson L. (Sweden) Aik S. (Malaysia) Begue T. C. (France) Birkholtz F. F. (South Africa) Blokhuis T. J. (Netherlands) Blonna D. (Italy) Bose D. (United Kingdom) Burkhart K. (Germany) Calder P. (United Kingdom) den Hartog D. (Netherlands) Donnan L. T. (Australia) Eilertsen L. (Norway) Ekholm C. (Sweden) Eygendaal D. (Netherlands) Faymonville C. (Germany) Fernandez F. (Germany) Ferreira N. (So...

1School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom; 2Haematology Department, Royal Bournemouth Hospital, Dorset, United Kingdom; 3Haematology Department, Heartlands Hospital, Birmingham, United Kingdom; 4Medical Research Council (MRC) Toxicology Unit, Leicester University, Leicester, United Kingdom; 5AstraZeneca Pharmaceuticals, Cambridge, United Kingdom; 6School o...

Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom; Department of Haematology, Nottingham University Hospital NHS Trust, Nottingham, United Kingdom; Department of Haematology, University Hospital of Wales Cardiff, United Kingdom; Department of Haematology, St Bartholomew’s Hospital, West Smithfield, London United Kingdom; Department of Haematology, Rigshos...

1Manchester University Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom; 2The United Kingdom National Haemophilia Database, Manchester, United Kingdom; 3Department of Haematology, Glasgow Hospital for Sick Children, Yorkhill, Glasgow, United Kingdom; 4Department of Haematology, Great Ormond Street Hospital, London, United Kingdom; 5Department of Haematology, The...

K. Ardeshna, W. Qian, P. Smith, L. Stevens, C. Pocock, M. Dyer, J. Davies, D. Cunningham, A. Kruger, D. Linch Department of Haematology, University College London Hospital, London, United Kingdom, On Behalf of UK NCRI Lymphoma Clinical Studies Group, MRC, Clinical Trials Unit, Oxford, United Kingdom, CR UK and UCL, Cancer Trials Center, London, United Kingdom, East Kent Hospitals, Canterbury, U...

New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom.

1Medicine, Imperial College London, London, United Kingdom; 2University of Cambridge, Cambridge, United Kingdom; 3Centre for Infections, Health Protection Agency, London, United Kingdom; 4Health Protection Agency Syndromic Surveillance Team, Birmingham, United Kingdom; 5Imperial College Healthcare NHS Trust, London, United Kingdom; 6Royal College of General Practitioners Research and Surveillan...

E. Orphanidou-Vlachou, D. Auer, J. Coupland, N. P. Davies, T. Jaspan, L. McPherson, K. Natarajan, D. Saunders, Y. Sun, T. Arvanitis, R. Grundy, and A. Peet University of Birmingham, Birmingham, United Kingdom, Birmingham Children's Hospital, Birmingham, United Kingdom, University of Nottingham, Nottingham, United Kingdom, Nottingham University Hospital, Nottingham, United Kingdom, University Ho...